EUVIMEDEUVIMED entdecken
Crossref

Recent developments and future perspectives in aging and macrophage immunometabolism

Brandt D. Pence

AIMS Molecular Science · 2021 · 8 (3) · 193-201

DOI: 10.3934/molsci.2021015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift AIMS Molecular Science, 2021. Verfasst von Brandt D. Pence. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 58 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aging is the strongest contributor to the development and severity of many chronic and infectious diseases, primarily through age-related increases in low-grade inflammation (inflammaging) and decreases in immune function (immunosenescence). Metabolic reprogramming in immune cells is a significant contributor to functional and phenotypic changes in these cells, but little is known about the direct effect of aging on immunometabolism. This review highlights several recent advances in this field, focusing on mitochondrial dysfunction, NAD+ metabolism, and therapeutic reprogramming in aged monocytes and macrophages. Perspectives on opportunities for future research in this area are also provided. Targeting immunometabolism is a promising strategy for designing therapeutics for a wide variety of age-related diseases.

Zitieren

APA

Pence, B. D. (2021). Recent developments and future perspectives in aging and macrophage immunometabolism. AIMS Molecular Science, 8(3), 193-201. https://doi.org/10.3934/molsci.2021015

Vancouver

Pence BD. Recent developments and future perspectives in aging and macrophage immunometabolism. AIMS Molecular Science. 2021;8(3):193-201. doi:10.3934/molsci.2021015

BibTeX
@article{Pence2021,
  author = {Pence, Brandt D.},
  title = {Recent developments and future perspectives in aging and macrophage immunometabolism},
  journal = {AIMS Molecular Science},
  year = {2021},
  volume = {8},
  number = {3},
  pages = {193--201},
  doi = {10.3934/molsci.2021015}
}
Kostenlos starten →